gyki 52466 has been researched along with Infarction, Middle Cerebral Artery in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gressens, P | 1 |
| Spedding, M | 1 |
| Gigler, G | 1 |
| Kertesz, S | 1 |
| Villa, P | 1 |
| Medja, F | 1 |
| Williamson, T | 1 |
| Kapus, G | 1 |
| Levay, G | 1 |
| Szenasi, G | 1 |
| Barkoczy, J | 1 |
| Harsing, LG | 1 |
1 other study available for gyki 52466 and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.
Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cell Survival; C | 2005 |